Results 201 to 210 of about 1,663,571 (298)

Extraintestinal Invasive Escherichia coli Infections in the US.

open access: yesJAMA Netw Open
Grome HN   +25 more
europepmc   +1 more source

Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections. [PDF]

open access: yesInfect Immun, 2018
Dbeibo L   +9 more
europepmc   +1 more source

Correction to: Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. [PDF]

open access: yesEur J Clin Microbiol Infect Dis, 2020
Loconsole D   +10 more
europepmc   +1 more source

Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. [PDF]

open access: yesEur J Clin Microbiol Infect Dis, 2020
Loconsole D   +10 more
europepmc   +1 more source

Antimicrobial Drug-Resistant Shiga Toxin-Producing Escherichia coli Infections, Michigan, USA. [PDF]

open access: yesEmerg Infect Dis, 2017
Mukherjee S   +6 more
europepmc   +1 more source

Biocatalysts for Peptide Geranylation With Linear and Cyclic Prenyl Groups

open access: yesAngewandte Chemie International Edition, EarlyView.
A combination of genome mining, synthetic biology, and biocatalytic assays revealed enzymes that install linear and cyclized prenyl moieties on ribosomally or chemically synthesized peptides. The promiscuity of both enzymes, while being specific for modification of C‐terminal tryptophans, enables enzymatic access to peptide terpenoid hybrids.
Sarolt Magyari   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy